filmov
tv
Pre ANDA Interactions with the FDA 6of16 Generic Drugs Forum 2020
Показать описание
Generic Program 2020 U.S. Food and Drug Administration Generic Program 2020 U.S. Food and Drug Administration
Khaled A. Omran
Рекомендации по теме
0:35:52
Pre-ANDA Interactions with the FDA (6of16) Generic Drugs Forum 2020
0:35:52
Pre ANDA Interactions with the FDA 6of16 Generic Drugs Forum 2020
0:46:47
Pre-ANDA Logistics and Best Practices (3of39) Complex Generics 2018
0:05:37
GDUFA II Training - Pre ANDA Product Development Meetings, Robert Lionberger
0:04:50
GDUFA II Training - Pre ANDA Program Pre Submission Meetings, Robert Lionberger
0:19:54
Pre-ANDA Program Update and Tips for Success – OPQ Perspective
0:20:56
Pre-ANDA Program Overview (2of39) Complex Generics 2018
0:38:23
ANDA Program Performance Review and Tips (8of16) Generic Drugs Forum 2020
0:23:06
GDUFA II Pre-ANDA Program Meetings: Advice for Success (10of27) Generic Drugs Forum 2018
0:14:41
D2,S7,S1-Pre-ANDA Evaluation of Drug Delivery Device Constituent
0:15:05
Pre-ANDA Meeting Requests for Orally Inhaled/Nasal Drugs(24of35) Complex Generics – Sep. 25-26, 2019...
2:26:13
Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval
0:20:08
505(b)(2) NDA or ANDA? (10of28) Generic Drugs Forum – Apr. 3-4, 2019
0:08:48
The art of misdirection | Apollo Robbins | TED
1:56:59
Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA
0:13:58
Guidance for Industry: Referencing Approved Drug Products in ANDA Submissions
0:31:03
ANDA Performance/Operations Update (3of27) Generic Drugs Forum April 2018
0:04:16
How stress affects your brain - Madhumita Murgia
0:31:34
ANDA Performance/Operations Update (3/28) Generic Drugs Forum 2017
0:03:21
When the Phone Rings | Episode 5 Pre-Release & Spoilers (ENG SUB)
1:11:57
Regulatory approval process | Timeline involve in IND | NDA | ANDA | Regulatory authoritie & age...
0:09:13
Your Arm Will Grow in No Time if You Do This : Arm Workout
0:53:44
Selecting and Submitting an ANDA Application
0:12:37
D2,S6,S4-Research Opportunities from ANDA Submissions Related to BE for Orally Inhaled Products